Theophilus Thepen

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

RWTH Aachen University(Current)

University of Cape Town

Fraunhofer Institute for Molecular Biology and Applied Ecology

Friedrich-Alexander-Universität Erlangen-Nürnberg

University Medical Center Groningen

Theophilus Thepen is an author at RWTH Aachen University specializing in therapeutic targeting of fusion proteins, immunotherapy, and cancer immunotherapy.

Publications per year

2015–2016

Publications

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model

Manal Amoury, Katharina Kolberg, Anh‐Tuan Pham et al. · Cancer Letters · 2016 · 43 citations

Medicine, Oncology, Pharmacology +13

A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein

Manal Amoury, Radoslav Mladenov, Thomas Nachreiner et al. · International Journal of Cancer · 2016 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +14

The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia

Radoslav Mladenov, Dmitrij Hristodorov, Christian Cremer et al. · International Journal of Cancer · 2015 · 16 citations · Full text

Life Sciences, Immunology, Oncology +14

1–3 of 3